Showing 9991-10000 of 19355 results for "".
- The FDA Approval of Inebilizumab for IgG4-Related Diseasehttps://reachmd.com/news/the-fda-approval-of-inebilizumab-for-igg4-related-disease/2475774/The FDA approval of Inebilizumab for IgG4-Related Disease marks a landmark in providing a targeted therapeutic option for a condition long underse
- Emerging Evidence in Probiotic Use in Neonatal Intensive Carehttps://reachmd.com/news/emerging-evidence-in-probiotic-use-in-neonatal-intensive-care/2475729/Emerging evidence reveals that probiotics in neonatal intensive care not only fortify intestinal defenses against necrotizing enterocolitis but also offer a strategy to restore microbiome homeostasis when essential medications induce dys
- New Frontiers in Chronic Kidney Disease: Noninvasive Diagnostics and Innovative Treatmentshttps://reachmd.com/news/new-frontiers-in-chronic-kidney-disease-noninvasive-diagnostics-and-innovative-treatments/2475734/Chronic Kidney Disease, affecting approximately 673 million individuals worldwide, is entering a new era of management through innovative noninvasive diagnostics and promisi
- Prognostic Impact of Para-Aortic Lymph Node Metastasis in Endometrial Cancerhttps://reachmd.com/news/prognostic-impact-of-para-aortic-lymph-node-metastasis-in-endometrial-cancer/2475721/A recent comprehensive analysis of risk factors and prognostic implications of para-aortic lymph node metastasis highlights the significant impact of para-aortic invol
- The Role of Genetic Screening and Cardiac Imaging in Diagnosing Transthyretin Amyloidosishttps://reachmd.com/news/the-role-of-genetic-screening-and-cardiac-imaging-in-diagnosing-transthyretin-amyloidosis/2475727/Exploring the pivotal role of genetic screening and cardiac imaging in enhancing the diagnosis of transthyretin amyloidosis. Cardiologists and neurologists increasingly face a diagnostic blind spot where progressive peripheral neuropathy overlaps with cardiac manifestation
- How Medications Are Reshaping the Gut Microbiome and Impacting Pathogen Growthhttps://reachmd.com/news/how-medications-are-reshaping-the-gut-microbiome-and-impacting-pathogen-growth/2475741/As medications increasingly interact with the gut microbiome, their potential to disrupt microbial balance and exacerbate pathogen growth is drawing critical attention from healthcare professionals. For clinicians oversee
- 3D-Printed Spinal Implants Reignite Nerve Regeneration Pathwayshttps://reachmd.com/news/3d-printed-spinal-implants-reignite-nerve-regeneration-pathways/2475736/3D-printed spinal implants deliver targeted electrical stimulation to reignite damaged nerve pathways in spinal cord injuries, dovetailing with advances in surgical
- Overcoming Imatinib Resistance in Gastrointestinal Stromal Tumors: New Frontiers in Precision Medicinehttps://reachmd.com/news/overcoming-imatinib-resistance-in-gastrointestinal-stromal-tumors-new-frontiers-in-precision-medicine/2475745/Oncologists are encountering increasing challenges as Gastrointestinal Stromal Tumors develop resistance to imatinib, necessitating the consideration of alternative tyrosine kinase inhibitors and advanced diagnostic techniques.
- Cognitive Impairment in MS: Innovative Paths to Enhanced Carehttps://reachmd.com/news/cognitive-impairment-in-ms-innovative-paths-to-enhanced-care/2475723/Cognitive impairment in multiple sclerosis is a quiet crisis that often leaves patients isolated and overlooked as standard pharmacologic regimens fall short of addressing mental fog and emotional distress. In routine neurology practic
- Redefining Gastrointestinal Surgery: Minimally Invasive Innovationshttps://reachmd.com/news/redefining-gastrointestinal-surgery-minimally-invasive-innovations/2475733/Minimally invasive techniques are redefining gastrointestinal surgery, offering safer and more efficient solutions for complex complications such as pouch outlet obstruction following vertical banded gastroplasty.